The Epilepsy Society is proud to be part of ground-breaking research which has revealed 26 potential new sites for epilepsy in our DNA, including 19 which are thought to be linked to Genetic Generalized Epilepsy. Additionally, the research has identified 29 genes which are thought to contribute to the development of epilepsy in these areas of […]
Aug 22, 2023 Rapid genome sequencing (rGS) testing is feasible to facilitate early diagnosis among infants with new-onset epilepsy, according to a study. The international, multicenter pilot cohort study is published in The Lancet Neurology.1 “The status quo has been to treat seizures like a symptom and try to find medications that alleviate them,” Annapurna Poduri, MD, […]
Latest Panel Analyzes 397 Genes Associated with Several Epilepsy Conditions, Offering an Analysis of Well-studied, Actionable Genes Related to Many Syndromic and Non-Syndromic Epileptic Disorders Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing and precision medicine, today announced the availability of an Epilepsy Panel and a STAT Epilepsy Panel – with the latter intended for […]
Epileptic encephalopathy is a group of neurologic conditions that involve severe epilepsy. In epileptic encephalopathy conditions, the seizures cause additional harm to the brain. Epileptic encephalopathy (EE) is a group of brain disorders that generally start in infancy but can begin during adulthood as well. They are characterized by severe, sometimes continuous, seizure activity that […]
About half of the time, the cause of epilepsy is unable to be identified. When a cause can’t be found, it is called cryptogenic epilepsy. For the other half of epilepsy cases, the causes may be more easily identifiable, such as head trauma or a known genetic syndrome. Read on to learn more about how genetics can […]
The risk of autistic disorders in children is increased more than two and a half times when Topiramate is consumed during pregnancy. This drug, used to treat epilepsy, also more than triples the risk of intellectual disability, a study has found. Topiramate, used to treat epilepsy or migraine, causes neurodevelopmental disorders in children exposed to […]
